167 related articles for article (PubMed ID: 23104203)
21. Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients.
Hirsch A; Yarur AJ; Dezheng H; Rodriquez D; Krugliak Cleveland N; Ali T; Hurst RD; Umanskiy K; Hyman N; Colwell J; Rubin DT
J Gastrointest Surg; 2015 Oct; 19(10):1852-61. PubMed ID: 26264361
[TBL] [Abstract][Full Text] [Related]
22. Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
Fan Y; Zhang L; Omidakhsh N; Bohn RL; Thompson JS; Brodovicz KG; Deepak P
Inflamm Bowel Dis; 2023 Jun; 29(6):914-922. PubMed ID: 35880838
[TBL] [Abstract][Full Text] [Related]
23. Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change.
Ordás I; Feagan BG; Sandborn WJ
Gut; 2011 Dec; 60(12):1754-63. PubMed ID: 21997558
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory bowel disease course in Crohn's disease: is the natural history changing?
Golovics PA; Mandel MD; Lovasz BD; Lakatos PL
World J Gastroenterol; 2014 Mar; 20(12):3198-207. PubMed ID: 24696605
[TBL] [Abstract][Full Text] [Related]
25. Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab.
Felipez LM; Gokhale R; Tierney MP; Kirschner BS
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):28-33. PubMed ID: 21681114
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic treatment of Crohn's complications.
Buda A; Okolo PI
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):887-95. PubMed ID: 24849124
[TBL] [Abstract][Full Text] [Related]
27. Infliximab in fistulizing Crohn's disease.
Osterman MT; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
[TBL] [Abstract][Full Text] [Related]
28. Assessment of stricturing Crohn's disease: Current clinical practice and future avenues.
Bettenworth D; Nowacki TM; Cordes F; Buerke B; Lenze F
World J Gastroenterol; 2016 Jan; 22(3):1008-16. PubMed ID: 26811643
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort.
Song XM; Gao X; Li MZ; Chen ZH; Chen SC; Hu PJ; He YL; Zhan WH; Chen MH
Dis Colon Rectum; 2011 Sep; 54(9):1147-54. PubMed ID: 21825896
[TBL] [Abstract][Full Text] [Related]
30. Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease.
Malgras B; Pautrat K; Dray X; Pasquier P; Valleur P; Pocard M; Soyer P
Dig Dis Sci; 2015 May; 60(5):1152-68. PubMed ID: 25381203
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications.
Mascarenhas C; Nunoo R; Asgeirsson T; Rivera R; Kim D; Hoedema R; Dujovny N; Luchtefeld M; Davis AT; Figg R
Am J Surg; 2012 Mar; 203(3):375-8; discussion 378. PubMed ID: 22364904
[TBL] [Abstract][Full Text] [Related]
32. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
33. Sequential therapies for Crohn's disease: optimizing conventional and biologic strategies.
Desilva S; Kaplan G; Panaccione R
Rev Gastroenterol Disord; 2008; 8(2):109-16. PubMed ID: 18641593
[TBL] [Abstract][Full Text] [Related]
34. An historical overview of the treatment of Crohn's disease: why do we need biological therapies?
Rutgeerts PJ
Rev Gastroenterol Disord; 2004; 4 Suppl 3():S3-9. PubMed ID: 15580150
[TBL] [Abstract][Full Text] [Related]
35. The natural history of adult Crohn's disease in population-based cohorts.
Peyrin-Biroulet L; Loftus EV; Colombel JF; Sandborn WJ
Am J Gastroenterol; 2010 Feb; 105(2):289-97. PubMed ID: 19861953
[TBL] [Abstract][Full Text] [Related]
36. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
37. [Different approaches for medical or surgical management of Crohn's disease: the importance of the classification of Vienna].
Colombo PL; Benedetti M; Tinozzi FP; Ticozzelli E; Maroni N; Di Sabatino A; Tinozzi S
Ann Ital Chir; 2006; 77(6):485-96. PubMed ID: 17343232
[TBL] [Abstract][Full Text] [Related]
38. Have biologics changed the natural history of Crohn's disease?
Mandel MD; Miheller P; Müllner K; Golovics PA; Lakatos PL
Dig Dis; 2014; 32(4):351-9. PubMed ID: 24969279
[TBL] [Abstract][Full Text] [Related]
39. Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children.
Kerur B; Machan JT; Shapiro JM; Cerezo CS; Markowitz J; Mack DR; Griffiths AM; Otley AR; Pfefferkorn MD; Rosh JR; Keljo DJ; Boyle B; Oliva-Hemker M; Kay MH; Saeed SA; Grossman AB; Sudel B; Kappelman MD; Schaefer M; Tomer G; Bousvaros A; Lerer T; Hyams JS; LeLeiko NS
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1467-1473. PubMed ID: 29486253
[TBL] [Abstract][Full Text] [Related]
40. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
Saad AM; Czul F; Sakuraba A; Rubin DT; Cohen RD
Inflamm Bowel Dis; 2016 May; 22(5):1027-31. PubMed ID: 26919459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
